You are here: Industry Insights > Influenza

News List

FluGen’s broadly protective flu vaccine clears early human test, eyes 'challenge' study fiercepharma
November 09, 2018
Every year, scientists have to choose which strains of flu virus to include in the coming season's flu shots, and when the vaccine strains don't match the circulating strains
Cell-derived flu vaccine strains a better match than eggs, Seqirus analysis finds fiercepharma
November 09, 2018
Flu vaccine efficacy problems were well documented throughout last year’s harsh season. Now the world’s largest cell-based vaccine producer, Seqirus, has published data
FDA approves first new influenza treatment in two decades pharmaceutical-technology
October 29, 2018
The US Food and Drug Administration (FDA) has granted approval of Xofluza (baloxavir marboxil) to Japanese pharmaceutical company Shionogi for the treatment of acute uncomplicated influenza (flu).
BiondVax's Universal Flu Vaccine Clinical Trial Completes First Season's Enrollment americanpharmaceuticalreview
October 25, 2018
BiondVax announced the successful enrollment of the last participant in the first season of a pivotal, clinical efficacy, Phase 3 trial of the M-001 universal flu vaccine candidate.
Roche unveils PhIII data for flu drug pharmatimes
October 11, 2018
Roche has unveiled late-stage data showing that its experimental antivrial drug baloxavir marboxil hit efficacy and safety targets in patients with flu.
Pre-clinical success for a universal flu vaccine offers hope for third generation approach worldpharmanews
September 26, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.
Influenza Caused Emirates Flight to Be Briefly Quarantined at JFK September 10, 2018
The mysterious illness that kept a plane away from the terminal after some passengers reported feeling sick has been confirmed as the flu, according to the New York City Department of Health and Mental Hygiene.
Global Influenza Therapeutics Market Report 2017-2025 - CAGR to Grow by 7.8% Allowing the Market to Reach $6 Billion biospace
March 26, 2018
The global Influenza therapeutics market was valued at US$ 6001.2 Million in 2016, and is expected to reach US$ 1204.1 Million by 2025, expanding at a CAGR of 7.8% from 2017 to 2025.
Let Data Talk: Is Nature or Humans to Blame for the Outbreak of Influenza this Winter? (2) Mr. Nanguo
January 29, 2018
Influenza: A natural disaster due to WHO’s errors in predicting influenza strains?
Let Data Talk: Is Nature or Humans to Blame for the Outbreak of Influenza this Winter? (1) Mr. Nanguo
January 29, 2018
Influenza has started to outbreak in China recently...

Previous page 1 2 3 4 5 6 Next page